. . . . . . . . . . . . "[A meta-analysis of all 15 randomized HRPBC trials (n = 6102) has detected an absolute 13% event-free survival benefit in favor of HDC (P = 0.0001) at a median 6-year follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2014-02-25"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2014-10-02T12:40:20+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .